Viatris* anticipates a short-term supply interruption which will affect the short-term availability of Xanax® (Alprazolam) in the UK.

We understand the importance for individuals prescribed Xanax® (Alprazolam) to have access to this medicine. Whilst we make every effort to ensure that our products are always available, on this occasion and due to administrative processes associated with importation/exportation impacting logistics, there is a short-term interruption in supply. The reason for the interruption in supply does not impact the quality, safety or efficacy of the finished product currently available on the market.

We are working with our third-party manufacturer and anticipate normal supply resuming in early January 2023.

If you have any questions about this letter, please contact Medical Information at the following address: Medical Information, Building 4, Trident Place, Mosquito Way, Hatfield, Hertfordshire, AL10 9UL, UK. Telephone: +44 (0)1707 853 000 or visit [email protected]

* Upjohn UK Limited is the Marketing Authorisation Holder, and they are now known as Viatris, a global healthcare company formed through the combination of Mylan and Upjohn in November 2020.